Yongliang Chu
State Key Laboratory Of Traditional Chinese Medicine Syndrome
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sweroside ameliorates rheumatoid arthritis-associated bone destruction by targeting Stat2-Drp1-dependent mitochondrial remodeling and reducing ROS production in osteoclastogenesis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 27, 2026
The efficacy and safety of iguratimod treatment in stable systemic lupus erythematosus: a preliminary prospective cohort study.
Journal: Frontiers in medicine
Published: February 13, 2026
Qifu Huazhuo formula for gout recurrence prevention: an interim analysis combining clinical outcomes with proteomic and metabolomic profiling.
Journal: Frontiers in pharmacology
Published: June 11, 2025
Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study.
Journal: JMIR public health and surveillance
Published: November 23, 2022
Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods.
Journal: BMC musculoskeletal disorders
Published: March 02, 2021
Metagenomic analysis revealed the potential role of gut microbiome in gout.
Journal: NPJ biofilms and microbiomes
Published: February 10, 2021
Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study.
Journal: Frontiers in medicine
Published: February 20, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026